Skip to main content
OpenTrials

Clinical trial condition

Hyperlipoproteinemia Type I

Explore clinical trials studying Hyperlipoproteinemia Type I. Study availability and eligibility vary by location and protocol.

13 public trials 2 recruiting studies

Hyperlipoproteinemia Type I trial results

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +9 more
Locations
  • Clinical Site 1 Boca Raton, Florida, United States
  • Clinical Site 2 Suwanee, Georgia, United States
  • Clinical Site 3 Indianapolis, Indiana, United States
  • Clinical Site 4 Elkridge, Maryland, United States
View all 58 locations
Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia, +10 more
Locations
  • Research Site 2 Camperdown, New South Wales, Australia
  • Research Site 5 Sippy Downs, Queensland, Australia
  • Research Site 3 Adelaide, South Australia, Australia
  • Research Site 4 Perth, Washington, Australia
Conditions
3-Hydroxy 3-Methyl Glutaric Aciduria, 3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency, 3-Hydroxy-3-Methylglutaryl-CoA Synthase 2 Deficiency, +368 more
Locations
  • CRMN, Hôpital La Citadelle Liège, Wallonia, Belgium
Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dyslipidemias, Familial Chylomicronemia Syndrome, +12 more
Locations
  • IONIS Investigative Site Huntington Beach, California, United States
  • IONIS Investigative Site San Francisco, California, United States
  • IONIS Investigative Site Boca Raton, Florida, United States
  • IONIS Investigative Site Boston, Massachusetts, United States
View all 34 locations